(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

Yan Wang,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536809044195

2009-01-01

Abstract:In the title compound, C(28)H(27)NO(2), the oxazinone ring adopts a twist-boat conformation and the cyclo-hexene ring has a twisted envelope conformation. The crystal structure is stabilized by weak non-classical inter-molecular C-H⋯O hydrogen bonds.

What problem does this paper attempt to address?

(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1H-2,3-benzoxazin-4-one

Yan Wang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536809044195

2009-01-01

Abstract:In the title compound, C28H27NO2, the oxazinone ring adopts a twist-boat conformation and the cyclohexene ring has a twisted envelope conformation. The crystal structure is stabilized by weak non-classical intermolecular C—H...O hydrogen bonds.
N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

Jia-Lu Luo,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536809028712

2009-01-01

Abstract:In the title compound, C(29)H(27)N(3)O(5), a dibenz[b,f][1,4]oxazepine derivative, the cyclo-hexane ring adopts a chair conformation, the oxazepine seven-membered ring has a twist-boat conformation, and the piperidin-2-one ring assumes a flattened boat conformation. Inter-molecular N-H⋯O hydrogen bonding between imino and nitro groups links two mol-ecules into a centrosymmetric dimer.
(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

Chao Wu,Yan-Jun Guo,Ai-Bao Xia

DOI: https://doi.org/10.1107/s1600536813008659

2013-01-01

Abstract:The title compound, C14H14BrNO4, contains a tricyclic ring system including three contiguous stereocenters all of which exhibit an R configuration. The cyclo-hexa-none ring adopts a chair conformation. The central oxane ring assumes a strained envelope conformation, with five of the ring atoms being nearly coplanar with the bromo-phenyl group and with the C atom adjacent to the O atom and fused with the cyclo-hexa-none ring as the flap. In the crystal, mol-ecules are linked into a three-dimensional network by C-H⋯O inter-actions.
6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

JX Xu,S Jin,ZY Zhang,TCW Mak

DOI: https://doi.org/10.1107/s0108270198005630

1998-01-01

Acta Crystallographica Section C Crystal Structure Communications

Abstract:The title compound, C31H24ClNO2S, has a cis-ring-fusion tricyclic structure, which is formed from a benzene ring, a seven-membered heterocyclic thiazepine ring and a 1,3-oxazinone ring. The 1,5-thiazepine ring has a slightly distorted boat-like conformation, whereas the 1,3-oxazinone ring adopts a half-chair conformation.
7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

Sz Jian,M Lei

DOI: https://doi.org/10.1107/S160053680502845X

2005-01-01

Abstract:In the title compound, C20H21NO3, the dihedral angle between the two benzene rings is 8.79 ( 7)degrees and the cyclohexane ring adopts a chair conformation. The molecules are linked by paired N-H O-... hydrogen bonds into centrosymmetric R-2(2)(8) dimers.
(S)-2-[(s,z)-3-bromo-1-nitro-4-phenylbut-3-en-2-yl]cyclohexanone

Chao Wu,Long Zhao,Ai-Bao Xia

DOI: https://doi.org/10.1107/s1600536811025633

2011-01-01

Abstract:In the crystal structure of the title compound, C(16)H(18)BrNO(3), the two stereogenic centres both have an S configuration. The cyclo-hexyl ring adopts a chair conformation. In the crystal, mol-ecules are linked by weak N-O⋯Br contacts [O⋯Br = 3.289 (4) Å].
(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

Benguo Lin,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536813002560

2013-01-01

Abstract:In the title compound, C(28)H(33)NO(4)·CH(2)Cl(2), the pyrrolidone ring adopts a twisted envelope conformation and the cyclo-hexene has a half-chair conformation. In the crystal, weak C-H⋯O hydrogen bonds link the components into chains along [100].
(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Jian Zhao,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536810017010

2010-01-01

Abstract:The title compound, C(28)H(26)N(2)O(4), crystallizes as a racemate with four stereogenic centers. In the molecule, the pyrrolidone ring adopts an envelope conformation and the cyclohexene ring has a twisted envelope conformation. In the crystal structure, molecules are linked by weak intermolecular C-H center dot center dot center dot O hydrogen bonds.
Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

chao wu,yanjun guo,xiaolong zhang,aibao xia

DOI: https://doi.org/10.1080/15421406.2014.928446

IF: 0.7

2015-01-01

Molecular Crystals and Liquid Crystals

Abstract:The title compound, (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one, was synthesized and characterized by H-1 and C-13 NMR and HRMS spectroscopy. Its absolute molecular configuration was investigated by X-ray crystallography. The crystal structure analysis revealed that the structure exhibits intermolecular hydrogen bonds of the type O-H horizontal ellipsis O. The methyl group and chlorophenyl group are located in the cis configuration. The conformation is stabilized by weak intermolecular C-H... O interactions.
(1′S,4′s)-5-(2,5-dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

Xing-Rui He,Bing-Rong Xu,Jing-Li Cheng,Jin-Hao Zhao

DOI: https://doi.org/10.1107/s1600536813005138

2013-01-01

Abstract:In the title compound, C18H23NO3, the cyclohexane ring has a chair conformation. The oxirane plane (OCC) makes a dihedral angle of 76.15 (13)degrees with that of the pyrrolidine ring to which it is fused. The mean plane of the cyclohexane ring and the benzene ring are almost normal to the pyrrolidine ring, with dihedral angles of 88.47 (8) and 77.85 (8)degrees, respectively. In the crystal, molecules are linked via pairs of N-H center dot center dot center dot O hydrogen bonds, forming inversion dimers. These dimers are linked via pairs of C-H center dot center dot center dot O hydrogen bonds, forming chains along the a-axis direction.
(1′S,4′S)-5-(2,5-Dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

Jin-Hao Zhao,Jing-Li Cheng,Bing-Rong Xu,Xing-Rui He

DOI: https://doi.org/10.1107/S1600536813005138

2013-01-01

Abstract:In the title compound, C18H23NO3, the cyclohexane ring has a chair conformation. The oxirane plane (OCC) makes a dihedral angle of 76.15 (13)° with that of the pyrrolidine ring to which it is fused. The mean plane of the cyclohexane ring and the benzene ring are almost normal to the pyrrolidine ring, with dihedral angles of 88.47 (8) and 77.85 (8)°, respectively. In the crystal, molecules are linked via pairs of N—H...O hydrogen bonds, forming inversion dimers. These dimers are linked via pairs of C—H...O hydrogen bonds, forming chains along the a-axis direction.
(1'S,4'S)-5-(2,5-Dimethyl-phen-yl)-4'-meth-oxy-6-oxa-3-aza-spiro-[bicyclo-[3.1.0]hexane-2,1'-cyclo-hexa-n]-4-one.

Xing-Rui He,Bing-Rong Xu,Jing-Li Cheng,Jin-Hao Zhao

DOI: https://doi.org/10.1107/S1600536813005138

2013-01-01

Abstract:In the title compound, C18H23NO3, the cyclo-hexane ring has a chair conformation. The oxirane plane (OCC) makes a dihedral angle of 76.15 (13)° with that of the pyrrolidine ring to which it is fused. The mean plane of the cyclo-hexane ring and the benzene ring are almost normal to the pyrrolidine ring, with dihedral angles of 88.47 (8) and 77.85 (8)°, respectively. In the crystal, mol-ecules are linked via pairs of N-H⋯O hydrogen bonds, forming inversion dimers. These dimers are linked via pairs of C-H⋯O hydrogen bonds, forming chains along the a-axis direction.
Ethyl (4aR*,7S*,8S*,8aS*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1H-isochromene-8-carboxylate

Xiu Qing Jiang,Jin-Long Wu

DOI: https://doi.org/10.1107/s1600536810017009

2010-01-01

Abstract:In the title compound, C18H20O4, both the tetrahydropyranone ring and the cyclohexene ring adopt envelope conformations. The crystal packing is stabilized by weak intermolecular C—H⋯O hydrogen bonding.
(5R,6r)-Methyl 6-Methyl-2-phenyl-5,6dihydro-4h-1,3-oxazine-5-carboxylate

Le Dai,Fen-Er Chen,Min-Qin Chen

DOI: https://doi.org/10.1107/s1600536807015991

2007-01-01

Abstract:The title compound, C13H15NO3, contains a chiral cisdisubstituted oxazine linked to a phenyl ring at the C-2 atom. The racemic crystal structure is stabilized by both intra- and intermolecular C-H center dot center dot center dot O hydrogen bonds.
N '-[(E)-2-hydroxybenzylidene]-5-methylisoxazole-4-carbohydrazide Monohydrate

Yan-Xian Jin,Zhen-Zhong Yan,Jian-Guo Yang,Ai-Guo Zhong,Fu-You Pan

DOI: https://doi.org/10.1107/s1600536809048028

2009-01-01

Abstract:In the structure of the title compound, C12H11N3O3 center dot H2O, the dihedral angle formed by the benzene and isoxazole rings is 2.03 (8)degrees. The molecular conformation is stabilized by an intramolecular O-H center dot center dot center dot N hydrogen bond. In the crystal structure, molecules are linked into a three-dimesional network by intermolecular N-H center dot center dot center dot O, O-H center dot center dot center dot N and O-H center dot center dot center dot O hydrogen bonds, and by pi-pi stacking interactions involving adjacent benzene and isoxazole rings [centroid-centroid separation = 3.663 (2)angstrom].
Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylate

Xing-Yao Li,Jin-Long Wu

DOI: https://doi.org/10.1107/S1600536812008136

2012-01-01

Abstract:In the title compound, C(13)H(13)NO(4), the fused-ring system is nearly planar, with an r.m.s. deviation of 0.0408 Å. In the crystal, mol-ecules are linked into centrosymmetric dimers by a pair of N-H⋯O hydrogen bonds. The ethyl group is disordered over two positions in a ratio of 0.758 (6):0.242 (6).
N-[2-(2-Methoxyphenyl)benzylidene]-tert-butyl-amine N-oxide.

Jin-Long Wu,Yu Liao,Shan-Lin Liu

DOI: https://doi.org/10.1107/s1600536808014529

2008-01-01

Abstract:In the mol-ecule of the title compound, C(18)H(21)NO(2), the two benzene rings are oriented at a dihedral angle of 58.19 (3)°. Intra-molecular C-H⋯O hydrogen bonds result in the formation of one six- and one five-membered ring, which adopt twist and envelope conformations, respectively. In the crystal structure, C-H⋯O hydrogen bonds link the mol-ecules.
4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

N Xue,YZ Hu

DOI: https://doi.org/10.1107/s1600536805042005

2005-01-01

Abstract:The structure of the title compound, C30H33N3O10, consists of an almost planar imidazolin-2-one system connecting two planar substituted phenyl groups and a roughly planar 3,4,5-trimethoxyanilinocarbonyl fragment which forms a dihedral angle of 95.17 (9)degrees with the heterocyclic ring.
(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

Qing Yuan,Ming Lei

DOI: https://doi.org/10.1107/s1600536806017296

2006-01-01

Abstract:The absolute configuration of the title compound, C20H26BrNO3, was determined from both the synthetic precursor and anomalous scattering effects. In the crystal structure, non-classical C—H...O hydrogen bonds link the molecules into a sheet parallel to the b axis.
4-Hydroxy-3-mesityl-1-oxaspiro[4.4]non-3-en-2-one

Jin-Hao Zhao,Yong Zhou,Guo-Nian Zhu,Jing-Li Cheng

DOI: https://doi.org/10.1107/s1600536809008617

2009-01-01

Abstract:In the title compound, C(17)H(20)O(3), the five-membered cyclo-pentyl ring displays an envelope conformation, with the atom at the flap position 0.538 (3) Å out of the mean plane formed by the other four atoms. The dihedral angle between the benzene and furan rings is 63.34 (15)°. In the crystal structure, mol-ecules are linked through inter-molecular O-H⋯O hydrogen bonds, forming a zigzag chain along [101].

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

(S)-2-[(s,z)-3-bromo-1-nitro-4-phenylbut-3-en-2-yl]cyclohexanone

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

(1′S,4′s)-5-(2,5-dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

(1′S,4′S)-5-(2,5-Dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

(1'S,4'S)-5-(2,5-Dimethyl-phen-yl)-4'-meth-oxy-6-oxa-3-aza-spiro-[bicyclo-[3.1.0]hexane-2,1'-cyclo-hexa-n]-4-one.

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

(5R,6r)-Methyl 6-Methyl-2-phenyl-5,6dihydro-4h-1,3-oxazine-5-carboxylate

N '-[(E)-2-hydroxybenzylidene]-5-methylisoxazole-4-carbohydrazide Monohydrate

Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylate

N-[2-(2-Methoxyphenyl)benzylidene]-tert-butyl-amine N-oxide.

4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

4-Hydroxy-3-mesityl-1-oxaspiro[4.4]non-3-en-2-one

(1S*,4aR*,5S*,6S*,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

(1<i>S</i>*,4a<i>R</i>*,5<i>S</i>*,6<i>S</i>*,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

N-Cyclo-hexyl-5H,7H-13,15-dimethyl-9-nitro-5-oxophenanthrido[4,4a,5-bc][1,4]benzoxazepine-7-carboxamide.

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

6-(4-Chlorophenyl)-3-methyl-2,4a-diphenyl-5,6-dihydro-1h,4ah-1,3-oxazino[2,3-d][1,5]benzothiazepin-1-one

7-(Benzyloxy)Spiro[2h-1,3-Benzoxazine-2,1 '-Cyclohexan]-4(3h)-One

(S)-2-[(s,z)-3-bromo-1-nitro-4-phenylbut-3-en-2-yl]cyclohexanone

(1S,3as,4s,7as)-Ethyl 1-Benzyl-2-(4-methoxybenzyl)-6,7-dimethyl-3-oxo-2,3,3a,4,5,7a-hexahydro-1h-isoindole-4-carboxylate Dichloromethane Monosolvate

(3ar*,6s*,7s*,7ar*)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

(1′S,4′s)-5-(2,5-dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

(1&#8242;S,4&#8242;S)-5-(2,5-Dimethylphenyl)-4&#8242;-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1&#8242;-cyclohexan]-4-one

(1'S,4'S)-5-(2,5-Dimethyl-phen-yl)-4'-meth-oxy-6-oxa-3-aza-spiro-[bicyclo-[3.1.0]hexane-2,1'-cyclo-hexa-n]-4-one.

Ethyl (4a<i>R</i>*,7<i>S</i>*,8<i>S</i>*,8a<i>S</i>*)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate

(5R,6r)-Methyl 6-Methyl-2-phenyl-5,6dihydro-4h-1,3-oxazine-5-carboxylate

N '-[(E)-2-hydroxybenzylidene]-5-methylisoxazole-4-carbohydrazide Monohydrate

Ethyl 4-methyl-1,3-dioxo-1,2,3,4-tetrahydroisoquinoline-4-carboxylate

N-[2-(2-Methoxyphenyl)benzylidene]-tert-butyl-amine N-oxide.

4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

4-Hydroxy-3-mesityl-1-oxaspiro[4.4]non-3-en-2-one

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(1′S,4′S)-5-(2,5-Dimethylphenyl)-4′-methoxy-6-oxa-3-azaspiro[bicyclo[3.1.0]hexane-2,1′-cyclohexan]-4-one

Ethyl (4a<i>R</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-1-oxo-7-phenyl-3,4,4a,7,8,8a-hexahydro-1<i>H</i>-isochromene-8-carboxylate